Our unique, injectable hydrogel platform provides localized, sustained drug delivery to improve patient outcomes across multiple therapeutic areas.
Transforming therapeutics to make a difference in patient health
AmacaThera’s Science
Grounded in the research of world-renowned biomaterials scientist, Dr. Molly Shoichet, we’re developing products at the intersection of biomaterials and pharmaceuticals.
Our Team
We’ve brought together commercial leaders, researchers and biotechnology experts that will transform therapeutics development while making a difference in patient outcomes.
Recent News
How AMT-143 could reduce the post-surgical need for opioids
In June 2022, we created and published “Meet AmacaThera and learn about our novel hydrogel platform,” a 35-second animation. Watch the animated explainer inside this article.Read more
AmacaThera featured in Innovate Toronto
AmacaThera’s drug development platform is featured in Innovate Toronto, an in-depth look at Toronto’s innovation ecosystem. The online compendium and coffee table book features over 300 start-up success stories, including Kepler, which aims to take the Internet into space, and Altus Assessments, which is using data and tech to bring the human side of healthcare education back into focus.
Read more